Lumos Pharma Inc (LUMO)
2.25
-0.04
(-1.75%)
USD |
NASDAQ |
May 31, 16:00
2.27
+0.02
(+0.89%)
After-Hours: 20:00
Lumos Pharma Price: 2.25 for May 31, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 31, 2024 | 2.44 | 2.445 | 2.25 | 2.25 | 13215.00 |
| May 30, 2024 | 2.30 | 2.365 | 2.24 | 2.29 | 20757.00 |
| May 29, 2024 | 2.36 | 2.39 | 2.30 | 2.31 | 6986.00 |
| May 28, 2024 | 2.42 | 2.439 | 2.30 | 2.31 | 22403.00 |
| May 24, 2024 | 2.47 | 2.520 | 2.28 | 2.451 | 65546.00 |
| May 23, 2024 | 2.48 | 2.625 | 2.35 | 2.50 | 15943.00 |
| May 22, 2024 | 2.516 | 2.660 | 2.516 | 2.57 | 6501.00 |
| May 21, 2024 | 2.575 | 2.64 | 2.504 | 2.52 | 15150.00 |
| May 20, 2024 | 2.65 | 2.695 | 2.515 | 2.62 | 51674.00 |
| May 17, 2024 | 2.64 | 2.64 | 2.42 | 2.54 | 7451.00 |
| May 16, 2024 | 2.22 | 2.67 | 2.22 | 2.63 | 44346.00 |
| May 15, 2024 | 2.45 | 2.55 | 2.01 | 2.24 | 138072.0 |
| May 14, 2024 | 2.80 | 2.888 | 2.44 | 2.55 | 85052.00 |
| May 13, 2024 | 2.82 | 2.93 | 2.761 | 2.875 | 11233.00 |
| May 10, 2024 | 3.05 | 3.05 | 2.73 | 2.90 | 32880.00 |
| May 09, 2024 | 3.05 | 3.19 | 2.99 | 3.02 | 31555.00 |
| May 08, 2024 | 2.98 | 3.03 | 2.96 | 3.000 | 12524.00 |
| May 07, 2024 | 2.96 | 3.07 | 2.917 | 3.02 | 26542.00 |
| May 06, 2024 | 3.05 | 3.05 | 2.91 | 3.00 | 43425.00 |
| May 03, 2024 | 3.00 | 3.05 | 2.90 | 2.96 | 69636.00 |
| May 02, 2024 | 3.05 | 3.06 | 2.98 | 3.04 | 128322.0 |
| May 01, 2024 | 2.76 | 3.07 | 2.725 | 3.02 | 278322.0 |
| Apr 30, 2024 | 2.81 | 2.90 | 2.70 | 2.81 | 19747.00 |
| Apr 29, 2024 | 2.78 | 2.923 | 2.77 | 2.83 | 13699.00 |
| Apr 26, 2024 | 2.744 | 2.78 | 2.744 | 2.77 | 688.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.24
Minimum
May 15 2024
35.91
Maximum
Dec 30 2020
9.387
Average
9.00
Median
May 01 2020
Price Benchmarks
| icad Inc | 1.45 |
| Perspective Therapeutics Inc | 1.38 |
| Palatin Technologies Inc | 1.80 |
| Bio-Path Holdings Inc | 2.10 |
| PDS Biotechnology Corp | 2.985 |
Price Related Metrics
| PS Ratio | 8.220 |
| PEG Ratio | -0.0212 |
| Price to Book Value | 1.047 |
| Earnings Yield | -243.6% |
| Market Cap | 18.26M |
| PEGY Ratio | -0.0212 |